GENE ONLINE|News &
Opinion
Blog

Celgene
Celgene Spinoff Arrives Wall Street with a $138 Million SPAC Deal
2021-07-19
Bristol-Myers Faces Lawsuit Claims Over Side-Stepping $6.4 Billion CVR Payment
2021-06-04
FDA Fast Tracks Celgene Spinoff’s NK Cell Therapy for Treating Aggressive Brain Tumor
2021-03-21
Bristol Myers Squibb Registers Another Trial Win for its Psoriasis Med
2021-02-03
Bristol Myers Squibb Notches Key Regulatory Win for Oral Formulation of Epigenetic Modifier
2020-09-06
BMS, bluebird bio’s Investigational BCMA CAR-T Therapy Faces Regulatory Setback
2020-05-18
JP Morgan Healthcare Conference 2020 Update: Bristol-Myers Squibb
2020-01-15
Celgene, Acceleron’s novel anemia drug gets FDA green light for rare blood disorder
2019-11-11
Top 3 Announcements at the J.P. Morgan Healthcare Conference 2019
2019-01-13
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top